Close

China Patent Enforcement Comments to USPTO

Nov 10 2011
The importance of intellectual property protection is now understood in China.  However, it appears as though the IP laws are implemented and enforced in ways that benefit Chinese companies over foreign companies.  If China aims to be a leader in biotechnology it needs to understand that intellectual property protections are fundamental for creating an enabling environment for biotechnology.  In this regard, China has yet far to go.

Comments of Biotechnology Industry Organization on Economic Analysis to Implement the Clean Fuel Standard

Oct 31 2011
Comments of Biotechnology Industry Organization on the Clean Air Association of the Northeast States (“NESCAUM”) Economic Analysis of a Program to Promote Clean Transportation Fuels in the Northeast/Mid-Atlantic Region.

Comments of Biotechnology Industry Organization on Economic Analysis to Implement the Clean Fuel Standard

Oct 31 2011
Comments of Biotechnology Industry Organization on the Clean Air Association of the Northeast States (“NESCAUM”) Economic Analysis of a Program to Promote Clean Transportation Fuels in the Northeast/Mid-Atlantic Region.

International IP and Small Businesses: Novavax CEO Testifies on BIO's Behalf

Oct 27 2011
Stanley C. Erck, President and CEO of Novavax testified at the USPTO on behalf of BIO to discuss the importance of IP protection internationally for small biotechnology companies.

Human Subject Research Protections: BIO Comments on HHS ANPRM on Human Subjects Research Protections (Common Rule)

Oct 26 2011

...

EHB: BIO Public Statement: Essential Health Benefits Listening Session

Oct 25 2011

...

Sunshine: BIO co-signs letter to HHS Secretary Kathleen Sebelius

Oct 25 2011

...

Sunshine Letter to HHS Secretary Kathleen Sebelius

Oct 25 2011
BIO signs on to letter to HHS Secretary Kathleen Sebelius, regarding the Physician Payments Sunshine Provision.

PDUFA V: BIO Supports Timely Reauthorization of PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients

Oct 24 2011

...

BIO Comments on the CARB on the Harmonization Chapter

Oct 21 2011
BIO comments on the draft “Harmonization” chapter (the chapter) of CARB report.